The DNA repair protein O6-methylguanine-DNA methyltransferase protects against skin tumor formation induced by antineoplastic chloroethylnitrosourea

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3335-3338

  Becker, Klaus ^a   Gregel, Cornelia M ^a   Kaina, Bernd ^b  

^a LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROETHYLNITROSOUREA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NIMUSTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CROSS LINKING; DNA ALKYLATION; DNA MODIFICATION; DNA REPAIR; GENE OVEREXPRESSION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SECOND CANCER; SKIN TUMOR; TRANSGENIC MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DNA MUTATIONAL ANALYSIS; GENES, RAS; HUMANS; METHYLTRANSFERASES; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NIMUSTINE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PAPILLOMA; POINT MUTATION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 0030749230     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Tew, K., Colvin, M., and Chabner, B. A. Alkylating agents. In: B. A. Chabner and D. L. Longo (eds.), Cancer Chemotherapy: Principles and Practice, 2nd ed. Philadelphia: J. B. Lippincott Co., 1995.
2. Kaldor, J. M., Day, N. E., Band, P., Choi, N. W., Clarke, E. A., Coleman, M. P., Hakama, M., Koch, M., Langmark, F., Neal, F. E., Pettersson, F., Pompe-Kirn, V., Prior, P., and Storm, H. H. Second malignancies following testicular cancer, ovarian cancer, and Hodgkin's disease: an international collaborative study among cancer registries. Int. J. Cancer, 39: 571-585, 1987.
3. Swertlow, A. J., Douglas, A. J., and Hudson, C. V. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphome Investigation. Br. Med. J., 304: 1137-1143, 1992.
4. Ludlum, D. DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal. Mutat. Res., 233: 117-126, 1990.
5. Erickson, L. C., Laurent, G., Sharkey, N. A., and Kohn, K. W. DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature (Lond.), 288: 727-729, 1980.
6. 1-deoxyguanosinyl)-ethan in the DNA treated with N,N′-bis(2-chloroethyl)-N-nitrosourea. Cancer Res., 42: 3102-3105, 1982.
7. Fram, R. J., Sullivan, J., and Marinus, M. G. Mutagenesis and repair of DNA damage caused by nitrogen mustard, N,N′-bis(2-chloroethyl)-N-nitrosourea (BCNU), streptozotocin, and mitomycin C in E. coli. Mutat. Res., 166: 229-242, 1986.
8. Bradley, M. O., Sharkey, N. A., Kohn, K. W., and Layard, M. W. Mutagenicity and cytotoxicity of various nitrosoureas in V-79 Chinese hamster cells. Cancer Res., 40: 2719-2725, 1980.
9. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some Antineoplastic and Immunosuppresive Agents, Vol. 26. Lyon, France: IARC, 1981.
10. Boice, J. D., Green, M. H., Killen, J. Y., Ellenberg, S. S., Keehn, R. J., McFadden, E., Chen, T. T., and Fraumeni, J. F. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N. Engl. J. Med., 309: 1079-1084, 1983.
11. Minnick, D. T., Veigl, M. L., and Sedgewick. W. D. Mutational specificity of 1,3-bis-(2-chloroethyl)-1-nitrosourea in a Chinese hamster ovary cell line. Cancer Res., 52: 4688-4695, 1992.
12. 6-alkylguanine-DNA alkyltransferase. Cancer Res., 53: 997-1003, 1993.
13. 6-methylguanine-DNA methyltransferase. Nucleic Acids Res., 11: 7743-7758, 1983.
14. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA, 87: 5368-5372, 1990.
15. 6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int. J. Cancer, 65: 506-512, 1996.
16. 6-methylguanine-DNA methyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides. Nucleic Acids Res., 16: 6779-6788, 1988.
17. 6-alkylguanine-DNA alkyltransferase. Science (Washington DC), 259: 219-222, 1993.
18. 6-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. Cancer Res., 50: 3244-3249, 1996.
19. Hogan, B. L. M., Beddington, R., Costantini, F., and Lacy, E. Manipulating the Mouse Embryo: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1994.
20. Brown, K., Bailleul, B., Ramsden, M., Fee, F., Krumlauf, R., and Balmain, A. Isolation and characterization of the 5′ flanking region of the mouse c-Harvey-ras gene. Mol. Carcinog., 1: 161-170, 1988.
21. 6-substituted guanine residues incorporated in codon 12 of the Ha-ras gene. Carcinogenesis (Lond.), 14: 593-598, 1993.
22. Brown, K., Buchmann, A., and Balmain, A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. USA, 87: 538-542, 1990.
23. 6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA, 90: 6468-6472, 1993.
24. Zaidi, N. H., Pretlow, T. P., O'Riordan, M. A., Dumenco, L. L., Allay, E., and Gerson, S. L. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the Ki-ras oncogene of mouse colon. Carcinogenesis (Lond.), 16: 451-456, 1995.
25. Tong, W. P., Kohn, K. W., and Ludlum, D. B. Modifications of DNA by different haloethylnitrosoureas. Cancer Res., 42: 4460-4464, 1982.
26. Briscoe, W. T., Anderson, S. P., and May, H. E. Base sequence specificity of three 2-chloroethylnitrosoureas. Biol. Pharmacol., 40: 1201-1209, 1990.
27. Lehmann, T. A., and Harris, C. C. Mutational spectra of proto-oneogenes and tumour suppressor genes: clues in predicting cancer etiology. In: K. Hemminki, A. Dipple, D. E. G. Shuker, F. F. Kadlubar, D. Segerbäck, and H. Bartsch (eds.), DNA Adducts: Identification and Biological Significance. IARC Scientific Publ. No. 125, pp. 399-412. Lyon, France: IARC, 1994.
28. Inga, A., Iannone, R., Campomenosi, P., Molina, F., Menichini, P, Abbondandolo, A., and Fronza, G. Mutational fingerprint induced by the antineoplastic drug chloroethyl-cyclohexyl-nitrosourea in mammalian cells. Cancer Res., 55: 4658-4663, 1995.
29. Inga, A., Iannone, R., Monti, P., Molina, F., Bolognesi, M., Abbondandolo, A., Iggo, R., and Fronza, G. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology. Oncogene, 14: in press, 1997.
30. Tucker, M. A., Caggana, M., Kelsey, K., and Coleman, C. N. Secondary cancers. In: J. F. Holland, E. Frei III, R. C. Bast, Jr., D. W. Kufe, D. L. Morton, and R. R. Weichelbaum (eds.), Cancer Medicine, pp. 2402-2415. Philadelphia: Lea & Febiger, 1993.
31. 6-benzylguanine plus BCNU. Blood, 88: 1649-1655, 1996.
32. Pelling, J. C., Neades, R., and Strawhecker, J. Epidermal papillomas and carcinomas induced in uninduced mouse skin by tumor promoters alone contain a point mutation in the 61st codon of the Ha-ras oncogene. Carcinogenesis (Lond.), 9: 665-667, 1988.
33. Bizub, D., Wood, A. W., and Skalka, A. M. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc. Natl. Acad. Sci. USA, 83: 6048-6052, 1986.
34. Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin Carcinogenesis. Nature (Lond.), 322: 78-80, 1986.